|
Feb 23
|
BioMarin (BMRN) Posts Q4 Earnings Beat, Upbeat Voxzogo Sales
|
|
Feb 23
|
Q4 2023 Biomarin Pharmaceutical Inc Earnings Call
|
|
Feb 23
|
20 Fastest Growing Biotech Companies in the US
|
|
Feb 23
|
BioMarin preaches patience amid slow sales for hemophilia gene therapy
|
|
Feb 22
|
Here's What Key Metrics Tell Us About BioMarin (BMRN) Q4 Earnings
|
|
Feb 22
|
BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings and Revenue Estimates
|
|
Feb 22
|
BioMarin Pharmaceutical Inc. (BMRN) Announces Record Financial Results for 2023
|
|
Feb 22
|
BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024
|
|
Feb 22
|
5 Stocks Likely to Gain on Q4 Earnings Today After Market Close
|
|
Jan 19
|
Zacks.com featured highlights Otter Tail, OraSure, BioMarin and Regeneron
|
|
Jan 15
|
BioMarin Pharmaceutical (BMRN) is a Top-Ranked Growth Stock: Should You Buy?
|
|
Jan 10
|
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
|
|
Jan 3
|
BioMarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, at 10:30 am PT / 1:30 pm ET, in San Francisco, CA
|
|
Dec 21
|
BioMarin strikes deal with Elliott, agrees to review business
|
|
Dec 20
|
BioMarin settles with Elliott, adds 3 independent directors
|
|
Dec 20
|
BioMarin Announces Governance Enhancements and Value Creation Initiatives
|
|
Dec 7
|
Why Is Denali Therapeutics Inc. (DNLI) Down 5.2% Since Last Earnings Report?
|
|
Dec 5
|
Billionaire Louis Bacon’s 10 Stock Picks with Huge Upside Potential
|
|
Dec 2
|
4 Preeminent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
|
|
Dec 1
|
Why Is BioMarin (BMRN) Up 14.3% Since Last Earnings Report?
|